A double-blind, multicentre, international randomised study to assess the effects of 6 months or 12 months administration of strontium ranelate versus biphosphonates on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosis

Trial Profile

A double-blind, multicentre, international randomised study to assess the effects of 6 months or 12 months administration of strontium ranelate versus biphosphonates on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosis

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Apr 2016

At a glance

  • Drugs Bisphosphonates; Strontium ranelate
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors IRIS
  • Most Recent Events

    • 17 Apr 2016 Results of a a sub- study (n=20) assessing bone quality at molecular level presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • 29 Jun 2012 Additional locations added as reported by European Clinical Trials Database.
    • 13 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top